Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapivirine Gel Rectal Safety and PK Study
NCT03044379Phase 1Withdrawn
- Sponsor
- International Partnership for Microbicides
- Start
- Sep 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in human immunodeficiency virus type 1 infection (HIV-1) comparing Dapivirine Gel with Placebo Gel HEC (2 arms). Primary endpoint: Safety and Pharmacokinetics. Planned start Sep 2015; status: withdrawn.
02
Drugs
dapivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03044379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03044379.